Galectin Therapeutics (GALT) vs Indaptus Therapeutics (INDP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Galectin Therapeutics is the larger company by market cap ($365.1 million vs $301.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | GALT | INDP |
|---|---|---|
| Share price | $3.62 | $2.26 |
| Market cap | $365.08M | $301.13M |
| 1-day change | -3.72% | -12.74% |
| YTD return | -12.98% | — |
| 1-year return | -24.11% | — |
| 5-year return | +7.42% | — |
| EPS (TTM) | $-0.43 | $-6.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.13 | $5.96 |
| 52-week low | $2.03 | $0.92 |
| Distance from 52-week high | -49.23% | -62.08% |
| Average volume | 387.94K | 822.38K |
| Shares outstanding | 100.85M | 133.24M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
GALT vs INDP FAQ
Which is bigger, Galectin Therapeutics or Indaptus Therapeutics?
Galectin Therapeutics (GALT) is larger, with a market capitalization of $365.08M compared with $301.13M for Indaptus Therapeutics (INDP).
Are Galectin Therapeutics and Indaptus Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.